Simplification Regimens

Comparison of Simplified, Class-sparing Antiretroviral Regimens 2/02/07

Simple Regimens Are Highly Effective in Developing World - 2/28/06

Simplification Therapy with Once-daily Didanosine, Tenofovir and Efavirenz: The EFADITE Trial - 12/05/05

Adherence Is Better after Switching from Twice-daily to Once-daily Therapy for HIV: Treatment Simplification Using Stavudine Prolonged-release Capsules - 5/25/05

48-week Efficacy of Once-daily Saquinavir Soft-gel/Ritonavir in Patients with Undetectable Viral Load after 3 Years of Antiretroviral Therapy - 4/06/05

Simplification Therapy with Once-daily Efavirenz, Emtricitabine and Didanosine in Patients Virologically Suppressed with a Protease Inhibitor-based Regimen - 3/21/05

Efavirenz with Two Nucleoside Analogs Is Superior for Regimen Simplification  - 2/28/05

Simplification Therapy with Once Daily Emtricitabine, Didanosine, and Efavirenz in HIV Positive Adults with Viral Suppression Receiving a Protease Inhibitor-based Regimen - 2/18/05

Substituting Abacavir for Hyperlipidemia-associated PIs Improves Lipid Profiles, Maintains Virologic Suppression, and Simplifies Treatment - 1/24/05